Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review

COVID 19 associated coagulopathy

OUTCOME OF CLINICAL PRESENTATIONS AND ABNORMAL COAGULATION PARAMETERS IN COVID-19 PATIENTS

Relation between Hypercoagulability Effect of COVID-19 and the Occurrence of Acute Coronary Syndrome

Assessment of the Natural Anticoagulants (Protein C, Protein S, and Antithrombin III) for COVID-19 Patients

Mesenteric Thrombosis as a Complication of COVID-19 Infection: A Systematic Review with Meta-Analysis

Endothelial glycocalyx shedding during active COVID-19 infection and its effect on disease severity

Study of Plasminogen activator inhibitor-1 (PAI-1) in hospitalized COVID-19 patients

A case report on therapeutic anticoagulation in the management of a COVID-19 patient on antiplatelets post-CABG — how much is enough?

BIOMARKERS OF COAGULATION ACTIVATION IN CHILDREN WITH SICKLE CELL DISEASE